Related Experiment Video
Updated: May 26, 2026
04:16
Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
Summary
Recent research offers improved support for Neonatal Intensive Care Unit (NICU) families. Advances in treating premature infants highlight the crucial role of human milk, with new findings shared by Professor Meier.
Area of Science:
- Neonatal Intensive Care
- Perinatology
- Infant Nutrition
Background:
- Significant research advancements have been made in supporting families with infants in the Neonatal Intensive Care Unit (NICU).
- Groundbreaking treatments for premature infants are emerging, with a particular focus on the benefits of human milk.
- International research is continuously evolving the understanding of neonatal care.
Purpose of the Study:
- To disseminate new findings on Neonatal Intensive Care Unit (NICU) family support and premature infant treatment.
- To highlight the role of human milk in neonatal care, based on recent international symposium presentations.
- To provide updated information and support for healthcare professionals working in or with NICUs.
Main Methods:
- Review of recent international research findings presented at a symposium.
- Synthesis of information on Neonatal Intensive Care Unit (NICU) support strategies.
- Compilation of data on advances in premature infant treatment, emphasizing human milk.
Main Results:
- Enhanced understanding of family support needs within the NICU setting.
- Identification of key advances in the treatment of premature infants.
- Emphasis on the critical role and benefits of human milk in neonatal intensive care.
Conclusions:
- Continued research is vital for improving outcomes for premature infants and their families.
- Human milk plays a pivotal role in neonatal intensive care, warranting further investigation and application.
- Dissemination of current research is essential for advancing best practices in NICU care.
More Related Videos
Related Concept Videos
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...